I agree with u Taureanbull , and would like to add that in November there was probably limited data showing from fewer trial patients. Now we have reached a point with a more significant number of patients. So no one will be able to claim the results might just be a lucky fluke on an insignificant handful, but rather consistent results showing a genuine extension of life, or progression free survival , across 20 or more patients due to HerVax working.
People should really start to get there heads around what some recent Big Pharma immuno oncology partnership deals look like.
At the Ph 2 stage. Right where we are now.
US$175million or more in upfront payments, more on further development milestones , 50% revenue sharing agreements, etc etc... multi billion dollar deals if exculsivity is included.
3.5c is a sick joke.
I agree with u Taureanbull , and would like to add that in...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $382.1K | 7.853M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 8072405 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 668099 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |